Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
29
WST Quote, Financials, Valuation and Earnings
Last price:
$221.65
Seasonality move
:
0.32%
Day range:
$221.40 - $226.03
52-week range:
$187.43 - $352.33
Dividend yield:
0.37%
P/E ratio:
35.22x
P/S ratio:
5.69x
P/B ratio:
6.01x
Volume:
365.7K
Avg. volume:
634.9K
1-year change:
-32.24%
Market cap:
$16.1B
Revenue:
$2.9B
EPS (TTM):
$6.37
Earnings Data
Next earnings date for WST
Jul 24
2025
Most recent earnings per share
$1.23
Missed by $0.03
(Apr 24/2025)
Consensus Estimate
$1.26
(Apr 24/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
WST Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $760.5M | -- | -- | $1.61 | -- |
| 07/24/2025 | Q2 | $725.3M | -- | -- | $1.51 | -- |
| 04/24/2025 | Q1 | $687.4M | $698M | $1.23 | $1.26 | -$0.03 |
| 02/13/2025 | Q4 | $740.9M | $748.8M | $1.78 | $1.73 | $0.05 |
| 10/24/2024 | Q3 | $709.6M | $746.9M | $1.85 | $1.49 | $0.36 |
| 07/25/2024 | Q2 | $728.7M | $702.1M | $1.51 | $1.73 | -$0.22 |
| 04/25/2024 | Q1 | $671.7M | $695.4M | $1.55 | $1.29 | $0.26 |
| 02/15/2024 | Q4 | $739.5M | $732M | $1.83 | $1.78 | $0.05 |
| 10/26/2023 | Q3 | -- | -- | $2.14 | $1.86 | $0.28 |
| 07/27/2023 | Q2 | -- | -- | $2.06 | $1.93 | $0.13 |
| 04/27/2023 | Q1 | -- | -- | $1.85 | $1.67 | $0.18 |
| 02/16/2023 | Q4 | -- | -- | $1.36 | $1.38 | -$0.02 |
| 10/27/2022 | Q3 | -- | -- | $1.59 | $2.12 | -$0.53 |
| 07/28/2022 | Q2 | -- | -- | $2.48 | $2.21 | $0.27 |
| 04/28/2022 | Q1 | -- | -- | $2.29 | $2.12 | $0.17 |
| 02/17/2022 | Q4 | -- | -- | $1.93 | $1.92 | $0.01 |
| 10/28/2021 | Q3 | -- | -- | $2.31 | $1.80 | $0.51 |
| 07/29/2021 | Q2 | -- | -- | $2.47 | $1.74 | $0.73 |
| 04/29/2021 | Q1 | -- | -- | $1.99 | $1.43 | $0.56 |
| 02/18/2021 | Q4 | -- | -- | $1.29 | $1.13 | $0.17 |
| 10/22/2020 | Q3 | -- | -- | $1.09 | $0.99 | $0.10 |
| 07/23/2020 | Q2 | -- | -- | $1.21 | $0.92 | $0.29 |
| 04/23/2020 | Q1 | -- | -- | $0.99 | $0.82 | $0.17 |
| 02/13/2020 | Q4 | -- | -- | $0.84 | $0.72 | $0.12 |
| 10/24/2019 | Q3 | -- | -- | $0.75 | $0.71 | $0.04 |
| 07/25/2019 | Q2 | -- | -- | $0.88 | $0.72 | $0.16 |
| 04/25/2019 | Q1 | -- | -- | $0.73 | $0.66 | $0.07 |
| 02/14/2019 | Q4 | -- | -- | $0.69 | $0.72 | -$0.03 |
| 10/25/2018 | Q3 | -- | -- | $0.73 | $0.70 | $0.03 |
| 07/26/2018 | Q2 | -- | -- | $0.75 | -- | -- |
| 04/26/2018 | Q1 | -- | -- | $0.58 | -- | -- |
| 02/15/2018 | Q4 | -- | -- | -- | -- | -- |
| 10/26/2017 | Q3 | -- | -- | $0.67 | -- | -- |
| 07/27/2017 | Q2 | -- | -- | $0.51 | -- | -- |
| 04/27/2017 | Q1 | -- | -- | $0.81 | -- | -- |
| 02/16/2017 | Q4 | -- | -- | $0.52 | -- | -- |
| 10/27/2016 | Q3 | -- | -- | $0.50 | -- | -- |
| 07/28/2016 | Q2 | -- | -- | $0.60 | -- | -- |
| 04/28/2016 | Q1 | -- | -- | $0.30 | -- | -- |
| 02/18/2016 | Q4 | -- | -- | $0.45 | -- | -- |
| 10/29/2015 | Q3 | -- | -- | $0.02 | -- | -- |
West Pharmaceutical Services Earnings Questions
-
How Much did West Pharmaceutical Services Generate in Revenue Last Quarter?
West Pharmaceutical Services reported $698M worth of top line sales in its most recent quarter.
-
Did West Pharmaceutical Services Beat Earnings Last Quarter?
West Pharmaceutical Services announced earnings per share of $1.23 which represents a miss of analyst forecast a $1.26 per share.
-
Is West Pharmaceutical Services Profitable?
West Pharmaceutical Services reported $231.9M that represents $3.18 per share over the last quarter.
-
What is the Analyst Consensus for West Pharmaceutical Services EPS Next Year?
West Pharmaceutical Services's earnings are forecast to decrease from $6.69 per share to $6.63 per share next year representing a decrease of -6.14%.
-
When is West Pharmaceutical Services's Earnings Date?
West Pharmaceutical Services's next earnings date is July 24, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
72
SBET alert for Jul 18
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
